FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to neurology, and concerns the treatment of cerebrovascular disorders of the brain. For this, against the background of conventional therapy, additionally, the administration of the drug "Raleukin" intravenously at a dose of 10–30 mg/kg or combined administration of "Raleukin" intravenously at a dose of 10–20 mg/kg and superoxide dismutase "Rexod" intravenously at a dose of 0.1–0.2 mg/kg.
EFFECT: this provides effective protection of the brain for various cerebrovascular disorders by blocking increased production of IL-1 cytokine and reducing oxidative stress.
2 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG FOR IMPROVING BLOOD SUPPLY OF ISCHEMIZED BRAIN | 2019 |
|
RU2747202C2 |
| METHOD FOR STROKE TREATMENT | 2014 |
|
RU2571282C1 |
| MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
| "PROMETEY" DIETIC FOOD PRODUCT HAVING REHABILITATION ACTION ON PATIENTS WHO SUFFERED ACUTE CEREBROVASCULAR DISEASES AND TRAUMATIC INJURIES OF CENTRAL NERVOUS SYSTEM LONG AGO | 2008 |
|
RU2368383C1 |
| MEANS FOR TREATING ISCHEMIA OF VASCULAR BRAINS | 2016 |
|
RU2625740C1 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| MEDICINAL AGENT OFFERING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTICONVULSANT EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2309745C2 |
| ANTIOXIDANT AND ANTIHYPOXIC AGENT OF 6-METHYL-2-ETHYL-3-HYDROHYPYRIDINE SUCCINATE | 2008 |
|
RU2398583C2 |
| AGENT FOR REDUCTION OF GLUTAMATE-INDUCED APOPTOSIS AND INHIBITION OF NMDA-RECEPTOR, POSSESSING IMMUNOMODULATORY ACTION, FOR TREATING NERVOUS SYSTEM DISORDERS, EFFECTS OF CRANIOCEREBERAL INJURY AND ISCHEMIC AND HEMORRHAGIC STROKE | 2013 |
|
RU2605339C2 |
